Latest profit margin for Aion Therapeutic: -451.18% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jan 2025
Trailing 12 months ending Jan 2025
Aion Therapeutic posts a profit margin of -451.18% as of January 2025. That compares with -725.69% in the prior-year period — up 37.8% year over year. That is below the sector sector average of 13.4%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Aion Therapeutic's profit margin was -725.69%. The latest reading is -451.18% — a 37.8% year-over-year increase (period ending January 2025). Use the history and growth charts on this page for a longer lookback.
For its sector stocks, a profit margin near 13.4% is typical. Aion Therapeutic's -451.18% is lower that level. That is roughly 3466.1% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Aion Therapeutic's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -451.18% as of January 2025; use YoY and peer views to separate noise from signal.
Context for ANTCF's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.4%), and (3) consistency with growth and profitability. This page covers the first two; Aion Therapeutic's other metric pages and overview cover the third.